{"task_id": "1fe07d206f48abeb", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 162/464)", "text": "Y CAUSES\ntreat underlying cause\n150\nThrombocytosis\n\n--- Page 172 ---\nThrombocytopenia\nDIFFERENTIAL DIAGNOSIS\nPSEUDOTHROMBOCYTOPENIA\nplatelet clump\ning (usually due to EDTA induced platelet activation)\nDILUTIONAL\nPRBC transfusion (at least 15 20\nunits), pregnancy\n# PRODUCTION\n\u0002\nINFILTRATIVE\nleukemia,\nMDS,\nbone\nmarrow\nmetastasis\n\u0002\nINFECTIONS\nHIV, rubella, mumps, varicella, par\nvovirus, HCV, EBV\n\u0002\nAPLASIA\naplastic anemia, Fanconi anemia\n\u0002\nTOXINS\nchemotherapy, radiation, alcohol\n\u0002\nB12/FOLATE DEFICIENCY\nHYPERSPLENISM\ncongestive, reactive, infiltra\ntive (see SPLENOMEGALY p. 164)\n\" DESTRUCTION\n\u0002\nIMMUNE THROMBOCYTOPENIC PURPURA\nprimary,\nsecondary (lymphoma, CLL, HIV, SLE, Evans\nsyndrome)\n\u0002\nALLOIMMUNE\npost transfusion,\npost transplanta\ntion\n\u0002\nMICROANGIOPATHIC HEMOLYTIC ANEMIA\ndissemi\nnated intravascular coagulation (DIC), thrombo\ntic thrombocytopenic purpura (TTP), hemolytic\nuremic syndrome (HUS), HELLP syndrome, anti\nphospholipid antibody syndrome\n\u0002\nINFECTIONS\nHIV, EBV, CMV\n\u0002\nMEDICATIONS\nheparin, GPIIb/IIIa inhibitors, qui\nnine, quinidine, valproic acid, thiazides, sulfona\nmides, rifampin, indomethacin, vancomycin,\nlinezolid\nPATHOPHYSIOLOGY\nDEFINITION\nplatelets < 150\u0003103/mL. However, an\nacute drop of 50%, even if the platelet count remains\nin the normal range, requires close monitoring and\npotential investigations\nLIFE CYCLE\nhalf life of platelets is 8 10 days. One\nthird of the total body platelets is found in the spleen\nBLEEDING RISK IN UNDER PRODUCTION\nTHROMBOCYTOPENIA\nPlatelet count\n(\u0003103/mL)\nBleeding risk\n>100\nMinimal symptoms\n50 100\nMinor symptoms\n10 50\nProne to bruises\n< 10\nRisk of spontaneous bleed\n(intracranial bleed)\nNOTE: in destruction or sequestration thrombocy\ntopenia, bleeding does not correlate with the mag\nnitude of thrombocytopenia\nCLINICAL FEATURES\nHISTORY\nmucocutaneous bleeding (epistaxis, pete\nchiae, easy bruising), abdominal pain, bloody diarrhea,\nrecent infections, fever, weight loss, past medical his\ntory (malignancy, HIV, ITP, alcohol), medications\n(heparin, GPIIb/IIIa inhibitors, quinine, ASA, NSAIDs)\nPHYSICAL\nvitals. Look for intracranial bleed (fun\ndoscopy), petechiae, and purpura. Check for lympha\ndenopathy and hepatosplenomegaly\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, peripheral smear,\nPTT, INR, AST, ALT, ALP, bilirubin, fibrinogen,\nLDH, ANA, vitamin B12, RBC folate, D dimer,\nHIV serology, hepatitis serology, Coombs test\nSPECIAL\n\u0002 HITT ASSAY\nheparin induced platelet aggrega\ntion assay, heparin PF4 solid phase immunoas\nsay, serotonin release assay\n\u0002\nBONE MARROW BIOPSY\nDIAGNOSTIC ISSUES\nSMEAR\n\u0002\nLARGE PLATELETS\ndestruction (ITP)\n\u0002\nSCHISTOCYTES/FRAGMENTS\nmicroangiopathic\nhemolytic anemia (DIC, TTP)\nBONE MARROW BIOPSY\n\u0002\nDECREASED MEGAKARYOCYTES\nunderproduction\n\u0002\nINCREASED\nMEGAKARYOCYTES\ndestruction/seques\ntration/MDS\nMANAGEMENT\nSYMPTOM CONTROL\nin under production throm\nbocytopenia, transfuse 5 U platelets if platelets\n<50\u0003103/mL\nand\nsevere\nbleeding,\nplatelets\n<10\u0003103/mL\nin\nafebrile\nnon bleeding\npatient,\n<20\u0003103/mL in febrile non bleeding patient, and\nprior to certain procedures (expect platelet rise of\n\u00055/unit). Note that platelet transfusions are not\neffective in ITP and may worsen TTP/HUS and HITT\nTREAT UNDERLYING CAUSE\ndiscontinue medi\ncations that may cause thrombocytopenia (platelets\nmay return to normal in 14 21 days). Please refer to\nspecific disorders below for details regarding treat\nment of each disease\nSPECIFIC ENTITIES\nMICROANGIOPATHIC\nHEMOLYTIC\nANEMIA\n(MAHA)\nalso called fragmentation hemolysis. Charac\nterized by non immune hemolytic anemia and schisto\ncytes. Causes include DIC, HELLP, TTP, HUS, malignancy,\nmalignant hypertension, artificial heart valve, insertion\nof foreign bodies, and medications\nThrombocytopenia\n151", "text_length": 3725, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 162/464)", "type": "chunk", "chunk_index": 161, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.468526", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.469421", "status": "complete", "chunks_added": 2}